Shire PLC (LON:SHP)‘s stock had its “buy” rating reissued by equities researchers at Citigroup Inc. in a research note issued to investors on Monday.

Other analysts also recently issued research reports about the company. Deutsche Bank AG reissued a “buy” rating and issued a GBX 6,000 ($78.32) price objective on shares of Shire PLC in a research note on Wednesday, July 13th. Liberum Capital reissued a “buy” rating and issued a GBX 5,500 ($71.79) price objective on shares of Shire PLC in a research note on Friday, July 29th. BNP Paribas reissued an “outperform” rating and issued a GBX 5,700 ($74.40) price objective on shares of Shire PLC in a research note on Monday, August 1st. Goldman Sachs Group Inc. reissued a “conviction-buy” rating and issued a GBX 6,300 ($82.23) price objective on shares of Shire PLC in a research note on Wednesday, August 3rd. Finally, Berenberg Bank reissued a “buy” rating and issued a GBX 5,800 ($75.71) price objective on shares of Shire PLC in a research note on Wednesday, July 6th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of GBX 5,841.33 ($76.25).

Shares of Shire PLC (LON:SHP) opened at 5278.00 on Monday. The firm has a 50-day moving average price of GBX 4,965.46 and a 200-day moving average price of GBX 4,445.48. Shire PLC has a 52 week low of GBX 2,707.19 and a 52 week high of GBX 5,333.00. The firm’s market capitalization is GBX 36.04 billion.

The company also recently announced a dividend, which will be paid on Friday, October 7th. Shareholders of record on Thursday, September 8th will be paid a GBX 3.51 ($0.05) dividend. The ex-dividend date of this dividend is Thursday, September 8th. This represents a yield of 0.07%.

In other news, insider Bohuon,Olivier bought 134 shares of the stock in a transaction on Thursday, June 30th. The shares were purchased at an average price of GBX 4,463 ($58.26) per share, for a total transaction of £5,980.42 ($7,806.32).

Shire PLC Company Profile

Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.

Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.